The Cost of Pharmaceutical Company Detailing Visits and Medication Samples-Reference-Cited by-同舟云学术

The Cost of Pharmaceutical Company Detailing Visits and Medication Samples

Published:2020-04-01 Issue:4 Volume:180 Page:595
ISSN:2168-6106
Container-title:JAMA Internal Medicine
language:en
Short-container-title:JAMA Intern Med

Author:

Guglielmo B. Joseph¹

Affiliation:

1. School of Pharmacy, University California, San Francisco

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Link

https://jamanetwork.com/journals/jamainternalmedicine/articlepdf/2759739/jamainternal_guglielmo_2020_il_190010.pdf

Reference7 articles.

1. A national survey of the frequency of drug company detailing visits and free sample closets in practices delivering primary care;King;JAMA Intern Med

2. National health care spending In 2016: spending and enrollment growth slow after initial coverage expansions.;Hartman;Health Aff (Millwood),2018

3. Medical marketing in the United States, 1997-2016.;Schwartz;JAMA,2019

4. Association between physicians’ interaction with pharmaceutical companies and their clinical practices: a systematic review and meta-analysis.;Brax;PLoS One,2017

5. Impact of pharmaceutical representative visits on GPs’ drug preferences.;Søndergaard;Fam Pract,2009

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of prescription drug samples in the US and implications for pharmacoepidemiologic research: a systematic search of the literature;Expert Review of Pharmacoeconomics & Outcomes Research;2021-04-29

2. Consider Everything When Prescribing Sacubitril/Valsartan;Journal of the American College of Cardiology;2020-09